ALLISON FLEMING: Open Payments
NPI 1861170136 · PORT HURON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 12 payments from 7 companies in 2025. Trend: 2023 $73 · 2024 $69 · 2025 $223
Food & beverage: $223
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Novo Nordisk Inc | 1 | $25 |
| Lundbeck LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Amgen Inc. | 1 | $15 |
Products named: REXULTI, CAPLYTA, BREZTRI, TRELEGY ELLIPTA, AIRSUPRA, REPATHA.
Industry payments across MI — which companies pay providers there.
